Oxytocin response to insulin-induced hypoglycemia in obese subjects before and after weight loss.
The response of plasma oxytocin to an iv bolus injection of crystalline insulin (0.15 U/kg) was evaluated in 14 normal weight [mean body mass index (BMI) = 23] and in 9 obese (mean BMI = 42) men. Similar blood glucose decrements after insulin injection were observed in the two groups. Obese and normal weight subjects presented similar basal oxytocin levels. In both groups, oxytocin rose significantly during the insulin tolerance test (ITT); however, the peak oxytocin response in the obese men was significantly lower than in the normal weight subjects. Obese men were restudied after substantial weight loss. Basal oxytocin levels and glucose response to insulin did not change after weight reduction. The oxytocin response to the ITT was significantly higher than before slimming and did not differ from that observed in the normal weight subjects. A significant negative correlation between BMI values and oxytocin peak levels during ITT was observed in the lean controls and obese subjects (r = 0.516, p less than 0.02). These results demonstrate that in obese subjects the oxytocin secretory response during an insulin tolerance test is reduced, suggesting the existence of a hypothalamic-pituitary disorder in obesity.
Coiro
V
V
Cattedra di Clinica Medica Generale, University of Parma, Italy.
Passeri
M
M
Davoli
C
C
d'Amato
L
L
Gelmini
G
G
Fagnoni
F
F
Schianchi
L
L
Bentivoglio
M
M
Volpi
R
R
Chiodera
P
P
D000328:Adult; D000906:Antibodies / Q000276:immunology; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007275:Injections, Intravenous; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D009765:Obesity / Q000378:metabolism*; D010121:Oxytocin / Q000276:immunology / Q000378:metabolism*; D011863:Radioimmunoassay; D013997:Time Factors
D000906:Antibodies; D001786:Blood Glucose; D007328:Insulin; D010121:Oxytocin